On June 25, 2025, two securities class action lawsuits were filed against Hims & Hers Health, Inc. (NYSE: HIMS) and certain of ...

InspireMD, Inc. NSPR recently announced the official commercial launch of the CGuard Prime Carotid Stent System in the United ...

It is unclear how the Trump administration will consider affordability when reviewing a drug, as prices are usually ...

Veteran captain alleges he was wrongly diagnosed with alcohol dependence following a head injury and coerced into United's ...

Hims & Hers will begin offering generic semaglutide drugs in Canada next year after Novo Nordisk lost its exclusive patent ...

A roundup of the most newsworthy healthcare press releases from PR Newswire, including a nasal spray for sleep apnea, a ...

Expert committee analysis in Hassan district reveals no significant increase in sudden heart attack deaths, recommends cardiac screening for drivers.

Backed by $1 million in funding from the CVS Health Foundation, the pilot initiative offers free, virtual health screenings to support aging with con ...

Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.